Skip to main content Skip to search Skip to main navigation

Remote, Distance, Offsite or Virtual Audits?

What is GMP Compliant and What is Reasonable?

12 min. reading time | by Thomas Peither
Published in LOGFILE 31/2021

Note: This is an abridged version.
The detailed version is available to the 
GMP Compliance Adviser customers.


There is no standard for GMP audits that are not carried out on site at the contractor's premises. Nevertheless, these remote audits, as I call them in the following, have become routine for all those who carry out audits.

A lot of information on remote audits has been published in the last few months and I have followed and analysed some of it. I hope there is also something for your everyday GMP life. This article looks at GMP audits and not at official GMP inspections. The latter are subject to other regulations and would go beyond the scope of this article.

Every company must operate GMP compliant processes and obtain as much information as possible from the supplier in a realistic manner.

It's best to look at the task from different angles - because that's how we make ourselves aware of the different problem points. And even after that, there is no single solution, but we look at a heterogeneous landscape of solutions. I leave it up to your expertise where you locate yourself.


The regulatory view

Audits differ from inspections in that inspections are carried out by competent authorities and audits are carried out between companies. In this context, the performance of audits is also frequently transferred to third-party companies, which then act on behalf of the contract giver. Audits are carried out for the

  • Review of outsourced activities and the
  • Supplier qualification.

Guidelines for the review of outsourced activities (in the long version)


Supplier qualification guidelines (in the long version)

[…]

EMA Notice to Stakeholders: Q&A on Regulatory Expectations for Medicinal Products for Human Use During the Covid-19 Pandemic (in the long version)

[…]

The current regulatory position

The current guidelines only provide clear requirements for a few GMP audits. Accordingly, audits at active ingredient manufacturers are only GMP compliant if they are carried out on site. The exception is the time when the pandemic is declared and travel restrictions that make an on-site audit impossible.

For all other audits an on-site audit is not stipulated by the GMP regulations and they can be designed with a comprehensible argumentation. Clients can therefore establish alternative processes in the form of remote audits, which can be GMP compliant.


The conservative view

"Remote audits do not represent reality truthfully", could be a conservative assessment of remote audits

This opinion can be substantiated with many shortcomings, disadvantages and technical problems of remote audits (see figure 1).

Disadvantages of remote audits
  • Plant tours of manufacturing facilities, warehouses and cleanrooms are difficult.
  • Details are lost with inadequate camera and transmission technology.
  • Auditors lose flexibility as they are more bound to a predefined framework.
  • Complex process flows or difficult spatial situations can only be reviewed to a limited extent.
  • On-site documents in production, warehouse and engineering can hardly be viewed spontaneously.
  • Sifting through documents on screen is tedious and comparisons with other documents are difficult, if not impossible.
  • The behaviour of employees can be more difficult to observe (inconspicuously).
  • Environmental conditions such as cleanliness, temperature, tightness, tidiness, etc. can only be tested to a limited extent or not at all.
  • Auditors are less able to follow their intuition and experience, as an overall picture is not transmitted.
  • IT security is only guaranteed to a limited extent for many digital systems.
  • The IT equipment at the client's and the contractor's premises does not allow for adequate auditing 

Figure 1   Disadvantages of remote audits

Considering all these disadvantages, one has to conclude that remote audits are insufficient. It is not compatible with GMP requirements to conduct remote audits as an alternative to on-site audits.

Consequently, all audits conducted as remote audits during the pandemic must also be repeated and confirmed by an on-site audit after the pandemic.


The progressive view

"We have seen a massive improvement in technology in recent months that allows us to evaluate companies at a distance from almost anywhere in the world," is the credo of those who would prefer not to travel at all.

[…]

The advantages are obvious for the supporters of this group and can be read in the long version of the article.  


A perspective for the future (in the long version)

[…]

Thomas Peither outlines a future perspective in which combinations of different audit forms (preparation off-site, remote audit, on-site audit) will play a role.


Summary (in the long version)

[…]



Do you have any questions or suggestions? Please contact us at: redaktion@gmp-verlag.de

Thomas Peither
Thomas Peither

You may also be interested in the following articles:

Outsourced Activities in the GDP Environment Part II: Contractual Agreements

Outsourced Activities in the GDP Environment Part II: Contractual Agreements

When outsourcing GDP activities, there is a need for concrete delimitation of responsibilities between a client and a contractor. Read more about the goals and the contents of a quality agreement in the following excerpt from GMP:KnowHow Pharmalogistics (GDP).

Read more
Question of the Week | GMP-Verlag

What are the Benefits and Limitations of Passive Temperature-Controlled Containers for Drug Transport?

Here's the answer:
Read more
FDA: Adjustment of Nitrosamine Limits for Short-Term Use Medicines

FDA: Adjustment of Nitrosamine Limits for Short-Term Use Medicines

The FDA has updated its recommendations on Acceptable Intake (AI) limits for nitrosamine impurities. Under certain conditions, the Agency now accepts a Less-Than-Lifetime (LTL) adjustment of AI limits for medicinal products that are not intended for lifetime use. This also represents an alignment with the LTL concept of ICH M7(R2).
Read more
Swissmedic: SMS Registration Becomes Prerequisite for GMP Certificates

Swissmedic: SMS Registration Becomes Prerequisite for GMP Certificates

As of 15 November 2026, active substances must be registered in the EMA's Substance Management Services (SMS) database before Swissmedic can include them in establishment licences and GMP certificates for active substance manufacturers. The new requirement results from modifications to the EudraGMDP database.
Read more
News: EMA

EMA: New Q&As for Biological Medicinal Products

The EMA has added a new section to its Q&As on biological medicinal products addressing medicinal products containing secretomes or extracellular vesicles (EVs) obtained from human or animal cells.
Read more
News: Europe

EU: Council Adopts the Pharmaceutical Package

On 28 September 2026, the Council of the European Union adopted the EU pharmaceutical package, marking another important step in the legislative process for the comprehensive reform of EU pharmaceutical legislation.
Read more
Previous
Next

Related Products

Skip product gallery
GMP Compliance Adviser | Named User Licence | 12M

GMP Compliance Adviser | Named User Licence | 12M

With an named user licence, one user can access the knowledge portal; with a corporate licence, any number of users can access it.Approx. 5,000 pages of practical GMP knowledge with illustrations and forms: Practical guidance for rapid implementation in the workplaceDetailed descriptions of GMP-compliant systemsInternational laws and guidelines Always up-to-date thanks to regular updates Download Advantages and Prices60+ Sample Documents In addition, the GMP Compliance Adviser contains more than 60 sample documents (MS Office) and practical examples that you can use.Sample SOPsSample FormsSample ReportsSample DocumentationChecklistsProcess Diagrams (Flowcharts)Practical Examples of QRM Application (e.g., Risk Analyses)Sample Documents for Qualification and ValidationCase StudiesWritten by more than 80 authors with hands-on experience directly linked to the industryA team of over 80 experts interpret regulatory requirements and describe how they are implemented in practice.The authors are experienced in the pharmaceutical industry, consulting, and government agencies.

delivery immediately after receipt of payment
€1,368.00 net excl. VAT
GMP:KnowHow Pharma Logistics (GDP) | Named User Licence | 12M

GMP:KnowHow Pharma Logistics (GDP) | Named User Licence | 12M

Your knowledge portal for GDP-compliant pharmaceutical logistics.  It is important that you as a logistics service provider, but also as a client in the pharmaceutical industry, comply with regulatory requirements. The GMP:KnowHow knowledge portal guides you through the complex regulatory landscape of the pharmaceutical and logistical supply chain! The knowledge portal gives you an easy-to-understand overview of all the important topics. Interactive graphics help you navigate all areas covered by the EU GDP Guidelines (2013/C 343/01). You also have the relevant passages of the regulations directly at hand for each topic. This allows you to compare the requirements directly and saves valuable research time.One thing is certain: the knowledge portal answers your questions about the supply chain of medicinal products, active pharmaceutical ingredients and medical devices. You don't have to be an expert. Yet.You will find answers to your questions in the GMP:KnowHow Pharma Logistics (GDP). Where does GDP begin, where does GMP end? What does GDP-compliant mean? When do I also have to take GMP requirements into account? What permits do I need for certain activities? What requirements do I have to fulfil? What is the current legal basis? How am I covered? What authorizations do I have for my work, e.g. from my employer? Who is responsible — the client or the contractor? And many more What is the difference to the GMP Compliance Adviser? GMP:KnowHow Pharma Logistics (GDP) is a practical knowledge portal dedicated to Good Distribution Practice (GDP). It is a product that is independent of the GMP Compliance Adviser and concentrates on content that is essential for carriers of medicinal products, active pharmaceutical ingredients and medical devices as well as for logistics clients. The focus is on practical knowledge and how to apply it in your daily business. If necessary, the relevant regulations can be called up immediately alongside the practical knowledge, and you can see the relevant paragraphs at a glance. In addition, sample documents are available to help you make immediate progress. AuthorSimone Ferrante, currently Director Quality at Fisher Clinical Services, previously served as Head of Quality Control and Responsible Person (GDP) for the Grieshaber Group. She is also a long-standing author and GDP expert at GMP-Verlag.

delivery immediately after receipt of payment
€610.00 net excl. VAT
E-Learning GMP:READY | Specialist Knowledge GMP for Engineers

E-Learning GMP:READY | Specialist Knowledge GMP for Engineers

Why are GMP rules important for technicians and engineers? Technicians and engineers play a key role in ensuring compliance with Good Manufacturing Practice (GMP) standards. They are involved in critical activities such as: planning and construction of ventilation systems, maintenance of water treatment plants, calibration of measuring sensors. Therefore, they are jointly responsible for the quality of medicines and must ensure that their work complies with GMP standards.Your advantages: Fast familiarization with GMP topics in approx. 2 hours, time- and location-independent online training, printable personal certificate, 12-month access for initial and follow-up training, automatic updates in case of legal changes,content compliant with Article 7(4) of Directive 2003/94/EC.The Author This e-learning course was developed with the collaboration of Dipl.-Ing. Andreas Nuhn (D & B Pharmadesign GmbH).

delivery time appr. 2-5 workdays after receipt of payment
€245.00 net excl. VAT
GMP Fundamentals | A Step-by-Step Guide

GMP Fundamentals | A Step-by-Step Guide

This handbook is a practical and easy to read guideline, giving you a quick and comprehensive overview of the complex world of Good Manufacturing Practice (GMP) without the need of previously acquired knowledge. Some topics are: GMP: Purpose and basic pharmaceutical terms Laws, licenses and inspections Personnel: Responsibility and hygiene Standard Operating Procedures (SOP) and documentation Design of rooms and facilities Processing and packaging Quality control and market release Suppliers, storage and logistics (Good Distribution Practice = GDP) Alphabetical index and abbreviations Using practical examples and comparisons to every-day life will help to easy understand GMP regulations.GMP Fundamentals is a helpful guide which facilitates the entry into the GMP world and teaches the necessary basics.

delivery immediately after receipt of payment
€44.90 net excl. VAT